{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:07:19Z","timestamp":1780078039215,"version":"3.54.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020166","name":"Flu Lab","doi-asserted-by":"publisher","award":["6001830"],"award-info":[{"award-number":["6001830"]}],"id":[{"id":"10.13039\/100020166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Non-pharmaceutical interventions (NPIs) such as mask use, physical distancing, business or school closure, and isolation have been central to controlling respiratory viral infections, including influenza, COVID-19, and respiratory syncytial virus (RSV). Understanding the preferences of the public and stakeholders for these interventions is critical to ensure their acceptability, uptake, and effectiveness. Discrete choice experiments (DCEs) provide a robust method to quantify how individuals value different attributes of NPIs and the trade-offs they are willing to make. However, evidence from DCEs is fragmented across diseases, populations, and methodological approaches. This scoping review aims to systematically map and synthesise evidence from DCEs examining public and stakeholder preferences for NPIs used in the prevention and control of influenza, COVID-19, and RSV. Specifically, it will: (1) summarise the attributes and attribute levels used in DCEs, and the methods employed to select them; and (2) identify which NPI attributes are most valued by the public and key stakeholders, including patients, healthcare workers, and policymakers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The review will follow the PRISMA-ScR framework. Comprehensive searches of electronic databases (PubMed, Scopus, and Embase) will identify DCEs evaluating NPIs for influenza, COVID-19, and RSV. Data extraction will capture study characteristics, target populations, attributes, experimental design, and analytical methods. Reporting quality will be appraised using the DIRECT Checklist. Given anticipated heterogeneity, findings will be synthesised narratively. By providing a structured overview of existing DCE evidence, this review will inform the design of future preference studies and guide the development of acceptable and evidence-based NPI strategies for respiratory viral infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Ethics and Dissemination<\/jats:title>\n                    <jats:p>No ethical approval is required. The completed review will be shared through peer-reviewed journals and conference presentations.<\/jats:p>\n                    <jats:p>\n                      Open Science Framework Registration\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/H36UC\" xlink:type=\"simple\">https:\/\/doi.org\/10.17605\/OSF.IO\/H36UC<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0344828","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:30:02Z","timestamp":1780075802000},"page":"e0344828","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence mapping of preference elicitation for non-pharmaceutical interventions targeting respiratory viral transmission: A scoping review protocol"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9690-3532","authenticated-orcid":true,"given":"Hui Yee","family":"Yeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3081-6778","authenticated-orcid":true,"given":"Lorraine","family":"Castelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"3","key":"pone.0344828.ref001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003550","article-title":"Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis","volume":"18","author":"KE Lafond","year":"2021","journal-title":"PLoS Med"},{"issue":"46","key":"pone.0344828.ref002","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1016\/j.vaccine.2013.09.013","article-title":"Influenza cost and cost-effectiveness studies globally--a review","volume":"31","author":"SK Peasah","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"pone.0344828.ref003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202787","article-title":"Health care costs of influenza-related episodes in high income countries: A systematic review","volume":"13","author":"C Federici","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"pone.0344828.ref004","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/HAB-200420","article-title":"Global burden of COVID-19: Situational analyis and review","volume":"29","author":"AA Gebru","year":"2021","journal-title":"Hum Antibodies"},{"key":"pone.0344828.ref005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2147\/CEOR.S338225","article-title":"Economic Burden of COVID-19: A Systematic Review","volume":"14","author":"F Richards","year":"2022","journal-title":"Clinicoecon Outcomes Res"},{"issue":"6","key":"pone.0344828.ref006","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/ppul.26370","article-title":"RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future","volume":"58","author":"RT Stein","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"31","key":"pone.0344828.ref007","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/j.vaccine.2022.05.077","article-title":"Estimating the burden of adult hospitalized RSV infection including special populations","volume":"40","author":"MP Nowalk","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"pone.0344828.ref008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.17219\/acem\/129573","article-title":"Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review","volume":"30","author":"J Czubak","year":"2021","journal-title":"Adv Clin Exp Med"},{"issue":"14","key":"pone.0344828.ref009","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.3390\/jcm14144894","article-title":"Comparative analysis of severe clinical outcomes in hospitalized patients with RSV, influenza, and COVID-19 across early and late COVID-19 pandemic phases (2021\u20132024)","volume":"14","author":"Y Xing","year":"2025","journal-title":"Journal of Clinical Medicine"},{"issue":"1","key":"pone.0344828.ref010","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41467-022-30897-1","article-title":"Untangling the changing impact of non-pharmaceutical interventions and vaccination on European COVID-19 trajectories","volume":"13","author":"Y Ge","year":"2022","journal-title":"Nat Commun"},{"key":"pone.0344828.ref011","unstructured":"Organization WH. Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza: annex: report of systematic literature reviews. 2019."},{"key":"pone.0344828.ref012","unstructured":"World Health Organization WH. Calibrating long-term non-pharmaceutical interventions for COVID-19: principles and facilitation tools. 2020."},{"issue":"5","key":"pone.0344828.ref013","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(20)30090-6","article-title":"Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study","volume":"5","author":"BJ Cowling","year":"2020","journal-title":"Lancet Public Health"},{"issue":"1","key":"pone.0344828.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2020.11.039","article-title":"Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden - a systematic review","volume":"82","author":"LM Fricke","year":"2021","journal-title":"J Infect"},{"issue":"1","key":"pone.0344828.ref015","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70066","article-title":"Assessing the Impact of Non\u2010Pharmaceutical Interventions During the COVID\u201019 Pandemic on RSV Seasonality in Europe","volume":"19","author":"S Heemskerk","year":"2025","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"6","key":"pone.0344828.ref016","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/23744235.2021.1894351","article-title":"Lessons to learn from the current pandemic for future non-pharmaceutical interventions against the respiratory syncytial virus - nationwide register-study in Finland","volume":"53","author":"I Kuitunen","year":"2021","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"pone.0344828.ref017","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12879-020-05340-9","article-title":"Improving the impact of non-pharmaceutical interventions during COVID-19: examining the factors that influence engagement and the impact on individuals","volume":"20","author":"H Seale","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"10","key":"pone.0344828.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258781","article-title":"Public perceptions of non-adherence to pandemic protection measures by self and others: A study of COVID-19 in the United Kingdom","volume":"16","author":"SN Williams","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"pone.0344828.ref019","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1257\/jel.20241649","article-title":"The Economics of Infectious Diseases","volume":"63","author":"MC Auld","year":"2025","journal-title":"Journal of Economic Literature"},{"issue":"4","key":"pone.0344828.ref020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s41649-022-00212-7","article-title":"Non-pharmaceutical Interventions and Social Distancing as Intersubjective Care and Collective Protection","volume":"14","author":"C Piroddi","year":"2022","journal-title":"Asian Bioeth Rev"},{"issue":"1","key":"pone.0344828.ref021","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1186\/s12889-018-5677-1","article-title":"The effects of public health policies on health inequalities in high-income countries: an umbrella review","volume":"18","author":"K Thomson","year":"2018","journal-title":"BMC Public Health"},{"issue":"9","key":"pone.0344828.ref022","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","article-title":"Discrete choice experiments in health economics: a review of the literature","volume":"32","author":"MD Clark","year":"2014","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"pone.0344828.ref023","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14737167.2.4.319","article-title":"Discrete choice experiments to measure consumer preferences for health and healthcare","volume":"2","author":"R Viney","year":"2002","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"9","key":"pone.0344828.ref024","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10198-022-01438-w","article-title":"Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics","volume":"23","author":"AC M\u00fchlbacher","year":"2022","journal-title":"Eur J Health Econ"},{"issue":"3","key":"pone.0344828.ref025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054155","article-title":"Public acceptability of non-pharmaceutical interventions to control a pandemic in the UK: a discrete choice experiment","volume":"12","author":"LE Lor\u00eda-Rebolledo","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0344828.ref026","article-title":"Public preferences for interventions to prevent emerging infectious disease threats: a discrete choice experiment","volume":"8","author":"AR Cook","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0344828.ref027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10198-022-01450-0","article-title":"Vaccination or NPI? A conjoint analysis of German citizens\u2019 preferences in the context of the COVID-19 pandemic","volume":"24","author":"J Bughin","year":"2023","journal-title":"Eur J Health Econ"},{"issue":"1","key":"pone.0344828.ref028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"H Arksey","year":"2005","journal-title":"International Journal of Social Research Methodology"},{"key":"pone.0344828.ref029","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1748-5908-5-69","article-title":"Scoping studies: advancing the methodology","volume":"5","author":"D Levac","year":"2010","journal-title":"Implement Sci"},{"issue":"7","key":"pone.0344828.ref030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"AC Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"pone.0344828.ref031","unstructured":"Cochrane JPTH. Cochrane handbook for systematic reviews of interventions. 2008."},{"issue":"1","key":"pone.0344828.ref032","first-page":"55","article-title":"Using discrete choice experiments to value health care programmes: current practice and future research reflections","volume":"2","author":"M Ryan","year":"2003","journal-title":"Appl Health Econ Health Policy"},{"key":"pone.0344828.ref033","volume-title":"Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza: annex: report of systematic literature reviews","author":"World Health Organization","year":"2019"},{"issue":"1","key":"pone.0344828.ref034","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"M Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"6","key":"pone.0344828.ref035","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hec.1739","article-title":"Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations","volume":"21","author":"J Coast","year":"2012","journal-title":"Health Econ"},{"issue":"10","key":"pone.0344828.ref036","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40273-024-01431-6","article-title":"A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist","volume":"42","author":"J Ride","year":"2024","journal-title":"Pharmacoeconomics"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:30:10Z","timestamp":1780075810000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0344828"}},"subtitle":[],"editor":[{"given":"Rakesh","family":"Sarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0344828","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]}}}